Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Finacity is a global leader in the receivables securitization and trade finance markets, providing specialized financial solutions to corporations worldwide. While not a life sciences company itself, Finacity frequently serves the healthcare, pharmaceutical, and medical device sectors by facilitating working capital through the securitization of trade receivables. The company manages over $100 billion in annual receivables volume and provides services including program administration, reporting, and asset-backed funding. Finacity was acquired by White Oak Global Advisors in 2021, further expanding its reach in the alternative investment and private credit space.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Finacity.